Savior Lifetec Corporation

Taipei Exchange 4167.TWO

Savior Lifetec Corporation Inventory for the year ending December 31, 2023: USD 28.02 M

Savior Lifetec Corporation Inventory is USD 28.02 M for the year ending December 31, 2023, a -17.13% change year over year. Inventory is the value of goods held by a company for sale or used in the production process.

Savior Lifetec Corporation Inventory for the year ending December 31, 2022 was USD 33.81 M, a -28.32% change year over year.
Savior Lifetec Corporation Inventory for the year ending December 31, 2021 was USD 47.16 M, a 23.00% change year over year.
Savior Lifetec Corporation Inventory for the year ending December 31, 2020 was USD 38.34 M, a 34.98% change year over year.
Savior Lifetec Corporation Inventory for the year ending December 31, 2019 was USD 28.41 M, a -14.09% change year over year.

Key data

Date	Inventory	Goodwill	Total Assets	Current Liabilities

Taipei Exchange: 4167.TWO

Savior Lifetec Corporation

CEO	Mr. Chih-Fang Chen
IPO Date	Dec. 21, 2012
Location	Taiwan
Headquarters	29, Ke-Jhong Road
Employees	384
Sector	Consumers Staples
Industries Cleaning Supplies Biotechnology Drugstores & Retail Pharmacies Fertilizers Personal Care Petrochemicals Pharmaceuticals Plastics

Description

Savior Lifetec Corporation, a specialty injectable company, produces and supplies sterile APIs and finished dosage formulations. The company offers imipenem and cilastatin sodium, an antibacterial agent for intravenous infusion; and meropenem, a beta-lactamase resistant carbapenem antibiotic for parenteral administration. It also provides ertapenem, a form of carbapenem for use on gram-negative and gram-positive anaerobes and aerobic. The company's pipeline products include SLC-006 for prostate cancer endometriosis uterine leiomyoma; and sterile paliperidone palmitate API for the treatment of schizophrenia. Savior Lifetec Corporation was founded in 2004 and is headquartered in Miaoli County, Taiwan.

Key trends

Past 5 years